Items where Author is "Mehling, M."

2016

Dimeloe, S. and Mehling, M. and Frick, C. and Loeliger, J. and Bantug, G. R. and Sauder, U. and Fischer, M. and Belle, R. and Develioglu, L. and Tay, S. and Langenkamp, A. and Hess, C.. (2016) The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol, 196 (1). pp. 106-114.

2015

Kappos, L. and Mehling, M. and Arroyo, R. and Izquierdo, G. and Selmaj, K. and Curovic-Perisic, V. and Keil, A. and Bijarnia, M. and Singh, A. and von Rosenstiel, P.. (2015) Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis. Neurology, 84 (9). pp. 872-879.

Mehling, M. and Frank, T. and Albayrak, C. and Tay, S.. (2015) Real-time tracking, retrieval and gene expression analysis of migrating human T cells. Lab on a Chip, 15 (5). pp. 1276-1283.

Mehling, M. and Burgener, A. V. and Brinkmann, V. and Bantug, G. R. and Dimeloe, S. and Hoenger, G. and Kappos, L. and Hess, C.. (2015) Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade. Scandinavian Journal of Immunology, 82 (5). pp. 460-466.

2014

Hegen, H. and Millonig, A. and Bertolotto, A. and Comabella, M. and Giovanonni, G. and Guger, M. and Hoelzl, M. and Khalil, M. and Killestein, J. and Lindberg, R. and Malucchi, S. and Mehling, M. and Montalban, X. and Polman, C. and Rudzki, D. and Schautzer, F. and Sellebjerg, F. and Sorensen, P. and Deisenhammer, F.. (2014) Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple sclerosis, Vol. 20, H. 5. pp. 577-587.

2013

Mehling, M. and Brinkmann, V. and Burgener, A. V. and Gubser, P. and Luster, A. D. and Kappos, L. and Hess, C.. (2013) Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade. Journal of allergy and clinical immunology, Vol. 131, H. 5 , S. 1440-1443 e7.

Mehling, M. and Fritz, S. and Hafner, P. and Eichin, D. and Yonekawa, T. and Klimkait, T. and Lindberg, R. L. and Kappos, L. and Hess, C.. (2013) Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNbeta-Therapy. PLoS ONE, Vol. 8, H. 11 , e78532.

2012

Gensicke, H. and Leppert, D. and Yaldizli, O. and Lindberg, R. L. and Mehling, M. and Kappos, L. and Kuhle, J.. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs, 26 (1). pp. 11-37.

2011

Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413.

Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.

Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213.

Benz, N. and Daikeler, T. and Frank, S. and Mehling, M. and Tyndall, A. and Trendelenburg, M.. (2011) Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity. BMJ case reports, 2011, Nov 8.

2010

Mehling, M. and Lindberg, R. and Raulf, F. and Kuhle, J. and Hess, C. and Kappos, L. and Brinkmann, V.. (2010) Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology, Vol. 75, H. 5. pp. 403-410.

2009

Kuhle, J. and Lindberg, R. L. P. and Regeniter, A. and Mehling, M. and Steck, A. J. and Kappos, L. and Czaplinski, A.. (2009) Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. European journal of neurology, Vol. 16. pp. 771-774.

Gugleta, K. and Kochkorov, A. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Retinal vessels in patients with multiple sclerosis : baseline diameter and response to flicker light stimulation. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 272-275.

Kochkorov, A. and Gugleta, K. and Kavroulaki, D. and Katamay, R. and Weier, K. and Mehling, M. and Kappos, L. and Flammer, J. and Orgül, S.. (2009) Rigidity of retinal vessels in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 226, H. 4. pp. 276-279.

2008

Mehling, M. and Drechsler, H. and Kuhle, J. and Hardmeier, M. and Doerries, R. and Ruegg, S. and Gass, A.. (2008) Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement. Journal of neurovirology, Vol. 14, H. 1. pp. 78-84.

Mehling, M. and Brinkmann, V. and Antel, J. and Bar-Or, A. and Goebels, N. and Vedrine, C. and Kristofic, C. and Kuhle, J. and Lindberg, R. L. and Kappos, L.. (2008) FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology, Vol. 71, H. 16. pp. 1261-1267.

Gugleta, K. and Mehling, M. and Kochkorov, A. and Grieshaber, M. and Katamay, R. and Flammer, J. and Orgül, S. and Kappos, L.. (2008) Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis. Klinische Monatsblätter für Augenheilkunde, Vol. 225, H. 5. pp. 408-412.